UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key markets SALT LAKE CITY, Utah, Oct. 16, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced
(Financial Post, 2025-10-16T11:03:49Z)